Akouos Inc.

13.57+0.5700+4.38%Vol 177.02K1Y Perf -38.22%
Jun 14th, 2021 16:00 DELAYED
BID13.60 ASK13.63
Open13.05 Previous Close13.00
Pre-Market- After-Market-
 - -  - -%
Target Price
30.00 
Analyst Rating
— — 0.00
Potential %
121.08 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap467.47M 
Earnings Rating
Price Range Ratio 52W %
10.14 
Earnings Date
5th Jul 2021

Today's Price Range

12.7714.06

52W Range

11.6430.67

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-0.80%
1 Month
9.44%
3 Months
-35.38%
6 Months
-31.22%
1 Year
-38.22%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
AKUS13.570.57004.38
AAPL130.483.13002.46
GOOG2 527.0413.11000.52
MSFT259.892.00000.78
XOM62.07-0.1000-0.16
WFC45.15-0.5300-1.16
JNJ165.370.41000.25
FB336.775.51001.66
GE13.47-0.2200-1.61
JPM157.57-2.7200-1.70
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.38-0.47-23.68
Q04 2020-0.49-0.3724.49
Q03 2020-0.39-0.85-117.95
Q02 2020--11.14-
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date5th Jul 2021
Estimated EPS Next Report-0.38
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume177.02K
Shares Outstanding34.45M
Trades Count2.11K
Dollar Volume34.39M
Avg. Volume180.82K
Avg. Weekly Volume92.43K
Avg. Monthly Volume107.16K
Avg. Quarterly Volume163.44K

Akouos Inc. (NASDAQ: AKUS) stock closed at 13.57 per share at the end of the most recent trading day (a 4.38% change compared to the prior day closing price) with a volume of 181.16K shares and market capitalization of 467.47M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 69 people. Akouos Inc. CEO is Emmanuel Simons.

The one-year performance of Akouos Inc. stock is -38.22%, while year-to-date (YTD) performance is -31.57%. AKUS stock has a five-year performance of %. Its 52-week range is between 11.64 and 30.67, which gives AKUS stock a 52-week price range ratio of 10.14%

Akouos Inc. currently has a PE ratio of -1.10, a price-to-book (PB) ratio of 1.51, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -23.38%, a ROC of -24.56% and a ROE of -26.00%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Akouos Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.38 for the next earnings report. Akouos Inc.’s next earnings report date is 05th Jul 2021.

The consensus rating of Wall Street analysts for Akouos Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Akouos Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Akouos Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Akouos Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 16.35, ATR14 : 0.93, CCI20 : 54.12, Chaikin Money Flow : 0.00, MACD : -0.05, Money Flow Index : 64.78, ROC : 9.88, RSI : 52.12, STOCH (14,3) : 61.67, STOCH RSI : 0.41, UO : 46.60, Williams %R : -38.33), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Akouos Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Akouos Inc.

Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearing. The company is involved in developing potential genetic medicines for a variety of inner ear disorders.

CEO: Emmanuel Simons

Telephone: +1 857 410-1818

Address: 645 Summer Street, Boston 02210, MA, US

Number of employees: 69

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

100%0%

News

Stocktwits